KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Invested Capital: 2009-2025

Historic Invested Capital for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to $2.5 billion.

  • Exact Sciences' Invested Capital fell 22.09% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 22.09%. This contributed to the annual value of $2.4 billion for FY2024, which is 24.82% down from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Invested Capital is $2.5 billion, which was up 1.30% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Invested Capital ranged from a high of $3.6 billion in Q1 2021 and a low of $2.4 billion during Q1 2025.
  • Its 3-year average for Invested Capital is $2.9 billion, with a median of $3.1 billion in 2023.
  • In the last 5 years, Exact Sciences' Invested Capital surged by 51.53% in 2021 and then declined by 24.82% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' Invested Capital stood at $3.4 billion in 2021, then dropped by 10.17% to $3.0 billion in 2022, then grew by 5.00% to $3.2 billion in 2023, then declined by 24.82% to $2.4 billion in 2024, then dropped by 22.09% to $2.5 billion in 2025.
  • Its Invested Capital stands at $2.5 billion for Q3 2025, versus $2.5 billion for Q2 2025 and $2.4 billion for Q1 2025.